Overview

Hematopoietic Stem Cell Transplantation Based on Pharmacokinetic and Pharmacodynamic Modeling

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
In this study the investigators plan to develop a method to determine optimal busulfan dose through pharmacokinetic study.
Phase:
Phase 1
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Busulfan